sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Pan, Yangbin ^a   Wan, Jianxin ^b   Liu, Yipeng ^a   Yang, Qian ^a   Liang, Wei ^a   Singhal, Pravin C ^c   Saleem, Moin A ^d   Ding, Guohua ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PHOSPHOLIPASE A2 GROUP IB; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 PROTEIN, HUMAN; PROTEIN BINDING;

ADULT; AGED; APOPTOSIS; BIOPSY; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PODOCYTE; SIGNAL TRANSDUCTION;

ADULT; AGED; APOPTOSIS; ARACHIDONIC ACID; BIOPSY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROUP IB PHOSPHOLIPASES A2; HUMANS; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PHOSPHORYLATION; PODOCYTES; PROTEIN BINDING; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84929596379     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06660     Document Type: Article

References (36)

1. Llorca, O. Extended and bent conformations of the mannose receptor family. Cell Mol Life Sci 65, 1302-10 (2008).
2. Ohara, O., Ishizaki, J. & Arita, H. Structure and function of phospholipase A2 receptor. Prog Lipid Res 34, 117-38 (1995).
3. Nangaku, M., Shankland, S. J. & Couser, W. G. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16, 1195-204 (2005).
4. Zhang, C. et al. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Biochim Biophys Acta 1803, 482-91 (2010).
5. Mundel, P. & Reiser, J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int 77, 571-80 (2010).
6. Wang, L. et al. Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice. Biochem Biophys Res Commun 444, 622-7 (2014).
7. Beck, L. J. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361, 11-21 (2009).
8. Hoxha, E. et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 82, 797-804 (2012).
9. Svobodova, B., Honsova, E., Ronco, P., Tesar, V. & Debiec, H. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 28, 1839-44 (2013).
10. Larsen, C. P. & Walker, P. D. Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy. Transplantation 95, 1259-62 (2013).
11. Triggiani, M., Granata, F., Giannattasio, G. & Marone, G. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol 116, 1000-6 (2005).
12. Hanasaki, K. & Arita, H. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. Prostaglandins Other Lipid Mediat 68-69, 71-82 (2002).
13. Makoto Murakami, Y. T. Y. M. Recent progress in phospholipase A2 research: From cells to animals to humans. Progress in Lipid Research 50, 152-192 (2011).
14. Yagami, T. et al. Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. J Neurochem 81, 449-61 (2002).
15. Praznikar, Z. J., Petan, T. & Pungercar, J. A neurotoxic secretory phospholipase A2 induces apoptosis in motoneuron-like cells. Ann N Y Acad Sci 1152, 215-24 (2009).
16. Lee, C. et al. Secretory phospholipase A2 induces apoptosis through TNF-alpha and cytochrome c-mediated caspase cascade in murine macrophage RAW 264.7 cells. Eur J Pharmacol 536, 47-53 (2006).
17. Peuravuori, H. J., Funatomi, H. & Nevalainen, T. J. Group I and group II phospholipases A2 in serum in uraemia. Eur J Clin Chem Clin Biochem 31, 491-4 (1993).
18. Jenko-Praznikar, Z., Petan, T. & Pungercar, J. Ammodytoxins efficiently release arachidonic acid and induce apoptosis in a motoneuronal cell line in an enzymatic activity-dependent manner. Neurotoxicology 35, 91-100 (2013).
19. Sivalingam, N., Basivireddy, J., Pulimood, A. B., Balasubramanian, K. A. & Jacob, M. Activation of phospholipase A2 is involved in indomethacin-induced damage in Caco-2 cells. Toxicol In Vitro 23, 887-96 (2009).
20. Augert, A. et al. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep 10, 271-7 (2009).
21. Yokota, Y., Higashino, K., Nakano, K., Arita, H. & Hanasaki, K. Identification of group X secretory phospholipase A(2) as a natural ligand for mouse phospholipase A(2) receptor. FEBS Lett 478, 187-91 (2000).
22. Cupillard, L. et al. Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor. J Biol Chem 274, 7043-51 (1999).
23. Zvaritch E. L. G. L. M. Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2. J Biol Chem. 271, 250-257 (1996).
24. Rouault M. L. C. C. B. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry. 46, 1647-1662 (2007).
25. Boilard, E. et al. Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor. Biochemistry 45, 13203-18 (2006).
26. Lambeau, G. & Lazdunski, M. Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol Sci 20, 162-70 (1999).
27. Bonventre, J. V. The 85-kD cytosolic phospholipase A2 knockout mouse: a new tool for physiology and cell biology. J Am Soc Nephrol 10, 404-12 (1999).
28. Valentin, E., Ghomashchi, F., Gelb, M. H., Lazdunski, M. & Lambeau, G. On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J Biol Chem 274, 31195-202 (1999).
29. Sapirstein, A. & Bonventre, J. V. Phospholipases A2 in ischemic and toxic brain injury. Neurochem Res 25, 745-53 (2000).
30. Shibata, N. et al. 4-Hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A(2) in cultured Ra2 microglial cells via MAPK pathways. Neuropathology 31, 122-8 (2011).
31. Fonteh, A. N., Atsumi, G., LaPorte, T. & Chilton, F. H. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J Immunol 165, 2773-82 (2000).
32. Levine, L. Stimulated release of arachidonic acid from rat liver cells by celecoxib and indomethacin. Prostaglandins Leukot Essent Fatty Acids 65, 31-5 (2001).
33. Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13, 630-8 (2002).
34. Coward, R. J. et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56, 1127-35 (2007).
35. Lundstrom, S. L. et al. HPLC/MS/MS-based approaches for detection and quantification of eicosanoids. Methods Mol Biol 579, 161-87 (2009).
36. Nicholas, S. B., Basgen, J. M. & Sinha, S. Using stereologic techniques for podocyte counting in the mouse: shifting the paradigm. Am J Nephrol 33 Suppl 1, 1-7 (2011).